908 Devices, Inc. (MASS)
8.03
-0.03
(-0.37%)
USD |
NASDAQ |
May 07, 12:04
908 Devices Cash from Investing (Quarterly) : -1.991M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp. | -3.988M |
| Abbott Laboratories | -20.32B |
| Accuray, Inc. | -5.596M |
| Alphatec Holdings, Inc. | -19.89M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.084M |
| Cash from Financing (Quarterly) | -2.047M |
| Free Cash Flow | -8.421M |
| Free Cash Flow Per Share (Quarterly) | 0.0284 |
| Free Cash Flow to Equity (Quarterly) | 1.206M |
| Free Cash Flow to Firm (Quarterly) | 1.044M |
| Free Cash Flow Yield | -2.84% |